JFG
EBS icon

Jefferies Financial Group’s Emergent Biosolutions EBS Stock Holding History

Jefferies Financial Group’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-13,000
Closed -$63.2K – 1433
2025
Q1 		$63.2K Hold
13,000
– – ﹤0.01% 1508
2024
Q4 		$124K Hold
13,000
– – ﹤0.01% 1443
2024
Q3 		$109K Buy
+13,000
New +$118K ﹤0.01% 1283
2023
Q4 		– Sell
-64,200
Closed -$218K – 1769
2023
Q3 		$218K Buy
64,200
+4,200
+7% +$23.3K ﹤0.01% 1323
2023
Q2 		$441K Buy
+60,000
New +$556K ﹤0.01% 1221

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OHA
Oak Hill Advisors New York $878M AUM 106.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Jefferies Financial Group's EBS Position: Q2 2025 in Review

Jefferies Financial Group sold out of Emergent Biosolutions (EBS) in Q2 2025, closing a stake of 13,000 shares — an estimated $63.2K sold.

Jefferies Financial Group first reported a position in EBS in Q2 2023 and held it in 5 quarters. The position peaked at $441K in Q2 2023. 161 funds tracked by Wall St. Rank hold EBS as of Q2 2025.

  • Jefferies Financial Group reported no remaining Emergent Biosolutions position as of Q2 2025 after selling out during the quarter.
  • Jefferies Financial Group sold 13,000 Emergent Biosolutions shares in Q2 2025, an estimated $63.2K.
  • Jefferies Financial Group first reported a position in Emergent Biosolutions in Q2 2023 and held it in 5 quarters.
  • Jefferies Financial Group's Emergent Biosolutions position peaked at $441K in Q2 2023.
  • 161 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2025.

Based on Jefferies Financial Group's 13F filing for Q2 2025, filed 12 Aug 2025.